Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...

Novo Nordisk (NVO) announced on Friday that it has secured a legal victory against compounders selling unauthorized versions ...

Novo Nordisk has notched a major legal win against compounding pharmacies that make copies of its diabetes and obesity drug ...

Novo Nordisk has awarded a 50 million kroner ($7.6M) grant to the University of Copenhagen to develop less processed ...

Trump proposed a change to Medicare price talks that has long been sought after by the pharmaceutical industry.

WEIGHT loss injections have become the holy grail in the fight against obesity, helping people shift the pounds they’ve been ...

Novo Nordisk (NYSE: NVO) has seen revenue soar in recent years thanks to two drugs that have helped people around the world ...

Fact checked by Nick Blackmer Hospital trips tied to semaglutide—the active ingredient in Ozempic and Wegovy—are rare, but ...

As meat alternative sales slide in the UK, a new crop of whole-food plant protein formats are on the rise – Oh So Wholesome's ...

Novo's Wegovy and Ozempic removed from US FDA shortage list, compounders on notice The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk's popular ...